UNSPSC 51131907: Human plasma protein fraction

This classification denotes a protein-based fluid (sometimes also called simulated body fluid) or that residual portion of blood that is left after removal of blood cells by centrifugation without prior blood coagulation, and proteins extracted therefrom, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6D53G0FD0Z. European Medicines Agency schedules Human Plasma Protein Fraction in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Indices SUB51727 and SUB22285 and SUB32334.

UNSPSC 51131907 Human plasma protein fraction is a Commodity code under which state and local governments procure therapeutic blood-derived products for hospital and healthcare system use. The code covers human plasma protein fractions — sterile, pyrogen-free solutions of human plasma proteins used for volume replacement, hemostasis support, and treatment of coagulation disorders in clinical settings. State and local health departments, hospital systems, public health agencies, and healthcare facilities sourcing blood products and derivatives use this code when acquiring plasma protein fractions from licensed manufacturers and blood product distributors.

The source provides no recent state and local contract opportunities under this code. Without posted solicitations, RFPs, RFQs, or ITBs naming human plasma protein fractions, the current procurement activity, issuing-body distribution, and geographic concentration cannot be characterized. Buyers of this commodity — typically centralized through state health department contracts, hospital cooperative purchasing agreements, or direct vendor relationships with blood banks and transfusion services — may not route individual acquisitions through the standard state and local procurement notice channels, or the code may see limited use in publicly posted solicitations relative to its actual procurement volume.